LiveASX is an independent website and is not affiliated with, endorsed by, or associated with ASX Limited.

AVECHO BIOTECHNOLOGY LIMITED (AVE)

Health care · Historical news and closing prices

Avecho Appoints Subaraj Subramaniam As CFO

AVE · Health care · 2026-10-27

Avecho Biotechnology has appointed Subaraj Subramaniam as chief financial officer, effective immediately, replacing Melanie Leydin, who has served the company since 2018. Subramaniam has more than 15 years’ accounting experience, including over seven years supporting ASX-listed companies.

Closing price · 2026-10-27: $0.014 · +0.00%